# Dapoxetine

## Priligy 30mg (3 tablets/box)

| TAH Drug Code      | [**OPRI**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OPRI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of premature ejaculation (PE) in men                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | 30 mg 1-3 hours prior to sexual activity. The recommended dose: 30mg/day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Hypersensitivity. Significant pathological cardiac conditions eg heart failure (NYHA class II-IV), conduction abnormalities (2nd- or 3rd-degree AV block or sick sinus syndrome) not treated w/ a permanent pacemaker, ischemic heart disease, valvular disease. Concomitant w/ MAOIs, thioridazine, selective serotonin re-uptake inhibitors (SSRIs), serotonin-norepinephrine re-uptake inhibitors (SNRIs), TCAs or other medicinal/herbal products w/ serotonergic effects (including recreational drugs), CYP3A4 inhibitors. Moderate & severe hepatic impairment (Child-Pugh class B & C). Childn <18 yr. |
| Adverse Effects    | Dizziness, headache, nausea, insomnia, anxiety, agitation, restlessness, decreased libido, abnormal dreams, somnolence, attention disturbance, tremor, paraesthesia, blurred vision, tinnitus, flushing, sinus congestion, yawning, GI disturbances, hyperhidrosis, erectile dysfunction, fatigue, irritability, increased BP                                                                                                                                                                                                                                                                                  |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

